519 related articles for article (PubMed ID: 28917515)
21. Clinical Outcome of Transcatheter Aortic Valve Replacement With TriGUARD 3™ Cerebral Embolic Protection Device.
Daal SM; Jimenez-Rodriguez GMJ; Voskuil M; Kraaijeveld AO; Dessing TC; Ramjankhan FZ; Mokhles MM; Stella PR
Cardiovasc Revasc Med; 2023 May; 50():8-12. PubMed ID: 36681530
[TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of cerebral protection devices in transcatheter aortic valve replacement: A clinical end-points meta-analysis.
Mohananey D; Sankaramangalam K; Kumar A; Jobanputra Y; Villablanca P; Krishnaswamy A; Mick S; Svensson LG; Tuzcu EM; Kapadia SR
Cardiovasc Revasc Med; 2018 Oct; 19(7 Pt A):785-791. PubMed ID: 29550047
[TBL] [Abstract][Full Text] [Related]
23. Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study.
Rodés-Cabau J; Kahlert P; Neumann FJ; Schymik G; Webb JG; Amarenco P; Brott T; Garami Z; Gerosa G; Lefèvre T; Plicht B; Pocock SJ; Schlamann M; Thomas M; Diamond B; Merioua I; Beyersdorf F; Vahanian A
JACC Cardiovasc Interv; 2014 Oct; 7(10):1146-55. PubMed ID: 25341709
[TBL] [Abstract][Full Text] [Related]
24. Cerebral embolic protection and severity of stroke following transcatheter aortic valve replacement.
Isogai T; Vanguru HR; Krishnaswamy A; Agrawal A; Spilias N; Shekhar S; Saad AM; Verma BR; Puri R; Reed GW; Popović ZB; Unai S; Yun JJ; Uchino K; Kapadia SR
Catheter Cardiovasc Interv; 2022 Nov; 100(5):810-820. PubMed ID: 35916117
[TBL] [Abstract][Full Text] [Related]
25. Impact of a Two-Filter Cerebral Embolic Protection Device on the Complexity and Risk of Transcatheter Aortic Valve Replacement.
Voss S; Deutsch MA; Schechtl J; Erlebach M; Sideris K; Lange R; Bleiziffer S
Thorac Cardiovasc Surg; 2020 Oct; 68(7):616-622. PubMed ID: 31091551
[TBL] [Abstract][Full Text] [Related]
26. Randomized Evaluation of TriGuard 3 Cerebral Embolic Protection After Transcatheter Aortic Valve Replacement: REFLECT II.
Nazif TM; Moses J; Sharma R; Dhoble A; Rovin J; Brown D; Horwitz P; Makkar R; Stoler R; Forrest J; Messé S; Dickerman S; Brennan J; Zivadinov R; Dwyer MG; Lansky AJ;
JACC Cardiovasc Interv; 2021 Mar; 14(5):515-527. PubMed ID: 33663779
[TBL] [Abstract][Full Text] [Related]
27. Clinical and hemodynamic results after direct transcatheter aortic valve replacement versus pre-implantation balloon aortic valvuloplasty: A case-matched analysis.
Ferrera C; Nombela-Franco L; Garcia E; Jimenez-Quevedo P; Biagioni C; Gonzalo N; Nuñez-Gil I; Viana-Tejedor A; Salinas P; Alberto de Agustin J; Almeria C; Islas F; Perez de Isla L; Fernandez-Perez C; Escaned J; Fernández-Ortiz A; Macaya C
Catheter Cardiovasc Interv; 2017 Nov; 90(5):809-816. PubMed ID: 27515377
[TBL] [Abstract][Full Text] [Related]
28. Aortic valve calcification as a risk factor for major complications and reduced survival after transcatheter replacement.
Pollari F; Hitzl W; Vogt F; Cuomo M; Schwab J; Söhn C; Kalisnik JM; Langhammer C; Bertsch T; Fischlein T; Pfeiffer S
J Cardiovasc Comput Tomogr; 2020; 14(4):307-313. PubMed ID: 31874792
[TBL] [Abstract][Full Text] [Related]
29. Cerebral Protection During Transcatheter Aortic Valve Implantation: An Updated Systematic Review and Meta-Analysis.
Testa L; Latib A; Casenghi M; Gorla R; Colombo A; Bedogni F
J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29728369
[TBL] [Abstract][Full Text] [Related]
30. Transcarotid transcatheter aortic valve replacement with cerebral embolic protection.
McGrath D; Salehi P; Weintraub A; Zhan Y
J Card Surg; 2022 Jun; 37(6):1779-1782. PubMed ID: 35301761
[TBL] [Abstract][Full Text] [Related]
31. Cerebral Embolic Protection and Stroke-Related Mortality Following Transcatheter Aortic Valve Replacement.
Isogai T; Bansal A; Vanguru HR; Agrawal A; Shekhar S; Puri R; Reed GW; Krishnaswamy A; Uchino K; Kapadia SR
JACC Cardiovasc Interv; 2022 Mar; 15(5):569-571. PubMed ID: 35272784
[No Abstract] [Full Text] [Related]
32. The Impact of Cerebral Embolic Protection Devices on Characteristics and Outcomes of Stroke Complicating TAVR.
Levi A; Linder M; Seiffert M; Witberg G; Pilgrim T; Tomii D; Barkan YT; Van Mieghem NM; Adrichem R; Codner P; Hildick-Smith D; Arunothayaraj S; Perl L; Finkelstein A; Loewenstein I; De Backer O; Barnea R; Tarantini G; Fovino LN; Vaknin-Assa H; Mylotte D; Wagener M; Webb JG; Akodad M; Colombo A; Mangieri A; Latib A; Kargoli F; Giannini F; Ielasi A; Søndergaard L; Aviram I; Lerman TT; Kheifets M; Auriel E; Kornowski R;
JACC Cardiovasc Interv; 2024 Mar; 17(5):666-677. PubMed ID: 38479966
[TBL] [Abstract][Full Text] [Related]
33. Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement.
Kapadia SR; Makkar R; Leon M; Abdel-Wahab M; Waggoner T; Massberg S; Rottbauer W; Horr S; Sondergaard L; Karha J; Gooley R; Satler L; Stoler RC; Messé SR; Baron SJ; Seeger J; Kodali S; Krishnaswamy A; Thourani VH; Harrington K; Pocock S; Modolo R; Allocco DJ; Meredith IT; Linke A;
N Engl J Med; 2022 Oct; 387(14):1253-1263. PubMed ID: 36121045
[TBL] [Abstract][Full Text] [Related]
34. Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN-TAVI registry.
Guedeney P; Tchétché D; Petronio AS; Mehilli J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Iadanza A; Sardella G; Van Mieghem NM; Sorrentino S; Claessen BEPM; Chandrasekhar J; Vogel B; Kalkman DN; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Ferrer-Grazia MC; Naber C; Kievit P; Baber U; Sharma S; Morice MC; Chieffo A; Mehran R;
Catheter Cardiovasc Interv; 2019 May; 93(6):1124-1131. PubMed ID: 30511802
[TBL] [Abstract][Full Text] [Related]
35. Predictors of Cerebral Embolic Debris During Transcatheter Aortic Valve Replacement: The SafePass 2 First-in-Human Study.
Grubman D; Ahmad Y; Leipsic JA; Blanke P; Pasupati S; Webster M; Nazif TM; Parise H; Lansky AJ
Am J Cardiol; 2023 Nov; 207():28-34. PubMed ID: 37722198
[TBL] [Abstract][Full Text] [Related]
36. Computed tomography predictors of mortality, stroke and conduction disturbances in women undergoing TAVR: A sub-analysis of the WIN-TAVI registry.
Spaziano M; Chieffo A; Watanabe Y; Chandrasekhar J; Sartori S; Lefèvre T; Petronio AS; Presbitero P; Tchetche D; Iadanza A; Van Mieghem NM; Mehilli J; Mehran R; Morice MC;
J Cardiovasc Comput Tomogr; 2018; 12(4):338-343. PubMed ID: 29735255
[TBL] [Abstract][Full Text] [Related]
37. Cerebral Embolic Protection and Outcomes of Transcatheter Aortic Valve Replacement: Results From the Transcatheter Valve Therapy Registry.
Butala NM; Makkar R; Secemsky EA; Gallup D; Marquis-Gravel G; Kosinski AS; Vemulapalli S; Valle JA; Bradley SM; Chakravarty T; Yeh RW; Cohen DJ
Circulation; 2021 Jun; 143(23):2229-2240. PubMed ID: 33619968
[TBL] [Abstract][Full Text] [Related]
38. Transcarotid Compared With Other Alternative Access Routes for Transcatheter Aortic Valve Replacement.
Chamandi C; Abi-Akar R; Rodés-Cabau J; Blanchard D; Dumont E; Spaulding C; Doyle D; Pagny JY; DeLarochellière R; Lafont A; Paradis JM; Puri R; Karam N; Maes F; Rodriguez-Gabella T; Chassaing S; Le Page O; Kalavrouziotis D; Mohammadi S
Circ Cardiovasc Interv; 2018 Nov; 11(11):e006388. PubMed ID: 30571205
[TBL] [Abstract][Full Text] [Related]
39. Insights on Embolic Protection, Repositioning, and Stroke: A Subanalysis of the RESPOND Study.
Seeger J; Falk V; Hildick-Smith D; Bleiziffer S; Blackman DJ; Abdel-Wahab M; Allocco DJ; Meredith IT; Wöhrle J; Van Mieghem NM
J Interv Cardiol; 2020; 2020():3070427. PubMed ID: 32518532
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of cerebral embolic protection devices in patients undergoing transcatheter aortic valve replacement: a meta-analysis of in-hospital outcomes.
Shimamura J; Kuno T; Malik A; Yokoyama Y; Gupta R; Ahmad H; Briasoulis A
Cardiovasc Interv Ther; 2022 Jul; 37(3):549-557. PubMed ID: 34773568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
